Gujarat, India

Vivek Farkade

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Intas Pharmaceuticals Limited. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vivek Farkade. Retrieved from https://idiyas.com/inventor/vivek-farkade

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vivek Farkade: Innovator in Biotechnology

Introduction

Vivek Farkade is a notable inventor based in Gujarat, India. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing biologically active proteins.

Latest Patents

Vivek Farkade holds a patent for a "Cloning, expression and purification method for the preparation of ranibizumab." This innovative method involves a polynucleotide sequence and a technique for cloning, expression, and production of Ranibizumab, which results in better yield and biologically active protein. He has 1 patent to his name.

Career Highlights

Farkade is currently employed at Intas Pharmaceuticals Limited, where he continues to work on advancements in biotechnology. His expertise in cloning and protein expression has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

He has collaborated with notable colleagues such as Harish Shandilya and Himanshu Gadgil, contributing to various projects that enhance the capabilities of their research and development efforts.

Conclusion

Vivek Farkade's work in biotechnology exemplifies innovation and dedication to improving pharmaceutical processes. His contributions are paving the way for advancements in the production of essential proteins.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…